Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05415410
What this trial is testing

Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)

Who this might be right for
GVHD
VectivBio AG 31
Testing effectiveness (Phase 2)Looking for participantsNCT07630727
What this trial is testing

Study of AHB-171 in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd. 138
Testing effectiveness (Phase 2)Study completedNCT01700036
What this trial is testing

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

Who this might be right for
Graft vs Host Disease
University of Michigan Rogel Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT01578707
What this trial is testing

Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 391
Not applicableEnded earlyNCT02935465
What this trial is testing

Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation

Who this might be right for
Chronic, Non-neuropathic Back Pain
University of Utah 17
Testing effectiveness (Phase 2)Study completedNCT00660530
What this trial is testing

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

Who this might be right for
HyperphosphatemiaKidney Disease
University of Illinois at Chicago 11
Not applicableStudy completedNCT00339209
What this trial is testing

Prospective Lung Transplant Database for Genetic Research

Who this might be right for
Lung Transplantation Rejection
National Institute of Environmental Health Sciences (NIEHS) 400
Large-scale testing (Phase 3)Study completedNCT00003414
What this trial is testing

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Who this might be right for
Graft Versus Host DiseaseLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableStudy completedNCT03054181
What this trial is testing

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Who this might be right for
Primary ImmunodeficiencySecondary Immune Deficiency
GWT-TUD GmbH 156
Early research (Phase 1)UnknownNCT05823675
What this trial is testing

Safety and Clinical Activity of Itolizumab in aGVHD

Who this might be right for
Acute Graft Versus Host Disease
Biotech Pharmaceutical Co., Ltd. 44
Very early researchNot Yet RecruitingNCT06949267
What this trial is testing

IMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-Host Disease
Ruijin Hospital 56
Not applicableEnded earlyNCT02338232
What this trial is testing

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD
Hackensack Meridian Health 32
Testing effectiveness (Phase 2)Study completedNCT00492921
What this trial is testing

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Who this might be right for
Graft Versus Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableStudy completedNCT04282421
What this trial is testing

Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France

Who this might be right for
Myelofibrosis
Central Hospital, Nancy, France 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597594
What this trial is testing

Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

Who this might be right for
Severe Combined Immunodeficiency
St. Jude Children's Research Hospital 4
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Early research (Phase 1)Looking for participantsNCT07070674
What this trial is testing

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

Who this might be right for
Acute Graft-versus-Host Disease
Accro Bioscience (Suzhou) Limited 24
Not applicableApproved For MarketingNCT03147742
What this trial is testing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Not applicableWithdrawnNCT05968170
What this trial is testing

TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute Myeloid Leukemia+3 more
Neena Kapoor, M.D.
Not applicableUnknownNCT02185261
What this trial is testing

Interferon α for the Therapy of Minimal Residual Disease

Who this might be right for
Leukemia
Peking University People's Hospital 81
Next Page